Human Papilloma Virus Typing at Large Loop Excision of the Transformation Zone of the Cervix Uteri

Anticancer Research

Volumn 23, Issue 5 B, 2003, Pages 4289-4292

  Negri, Giovanni ^a   Gampenrieder, Josef ^b   Vigl, Eduard Egarter ^a   Haitel, Andrea ^c   Menia, Erica ^a   Mian, Christine ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b Hospital of Merano   (Italy)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cervical intraepithelial neoplasia; HPV; Recurrence

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SURGERY; CONTROLLED STUDY; CYTOLOGY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; LARGE LOOP EXCISION OF THE TRANSFORMATION ZONE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0344872697     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gardeil F, Barry-Walsh C, Prendiville W, Clinch J and Turner MJ: Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol 89(3): 419-422, 1997.
2. Hulman G, Pickles CJ, Gie CA, Dowling FM, Stocks PJ and Dixon R: Frequency of cervical intraepithelial neoplasia following large loop excision of the transformation zone. J Clin Pathol 51(5): 375-377, 1998.
3. Chew GK, Jandial L, Paraskevaidis E and Kitchener HC: Pattern of CIN recurrence following laser ablation treatment: long-term follow-up. Int J Gynecol Cancer 9(6): 487-490, 1999.
4. Zaitoun AM, McKee G, Coppen MJ, Thomas SM and Wilson POG: Completness of excision and follow up cytology in patients treated with loop excision biopsy. J Clin Pathol 53: 191-196, 2000.
5. Livasy CA, Maygarden SJ, Rajaratnam CT and Novotny DB: Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: A study of margin, endocervical gland, and quadrant involvement. Mod Pathol 12(3): 233-238, 1999.
6. Narducci F, Occelli B, Boman F, Vinatier D and Leroy JL: Positive margins after conization and risk of persistent lesion. Gynecol Oncol 76(3): 311-314, 2000.
7. Denehy TR, Gregori CA and Breen JL: Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 90(1): 1-6, 1997.
8. Presley JJ, Hernandez E, Mundafort E and Miyazawa K: Endometrial and endocervical curettage findings at the time of cervical conization. J Reprod Med 32(2): 99-102, 1987.
9. Clavel C, Masure M, Putand I, Thomas K, Bory J-P, Gabriel R, Quereux C and Birembaut P: Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 51: 737-740, 1998.
10. Fait G, Daniel Y, Kupfermine MJ, Lessing JB, Niv J and Bar-Am A: Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical abnormalities? Gynecol Oncol 70: 319-322, 1998.
11. Manos MM, Kinney WK, Hurley LB et al: Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 218(17): 1605-1610, 1999.
12. Lin CT, Tseng CJ, Lai CH, Hsueh S, Huang HJ and Law KS: High-risk HPV DNA dDetection by hybrid capture II. An adjunctive test for mildly abnormal cytologic smears in women ≥ 50 years of age. J Reprod Med 45: 345-350, 2000.
13. Shlay JC, Dunn T, Byers T, Baron A and Douglas JM: Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on Papanicolaou smears. Obstet Gynecol 96: 410-416, 2000.
14. Chua KL and Hjerpe A: Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 66(1): 108-113, 1997.
15. Nagai Y, Maehama T, Asato T and Kanazawa K: Persistence of human papillomavirus infection after therapeutic conization for CIN3: is it an alarm for disease recurrence? Gynecol Oncol 79(2): 294-299, 2000.
16. Clavel C, Masure M, Bory J-P et al: Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. B J Cancer 80(9): 1306-1311, 1999.
17. Riethmuller D, Gay C, Bertrand X et al: Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determinated by Hybrid Capture II and polymerase chain reaction. Diagn Mol Patol 8(3): 157-164, 1999.
18. Kristensen GB, Skyggebjerg K-D, Holund B, Holm K and Hansen MK: Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. Acta Cytol 35: 47-50, 1991.
19. Jain S, Tseng C-J, Horng S-G, Soong Y-K and Pao C: Negative predictive value of human papilloma virus test following conization of the cervix uteri. Gynecol Oncol 82: 177-180, 2001.
20. Lin C-T, Tseng C-J, Lai C-H et al: Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 184: 940-945, 2001.
21. Frauchiger WL, De Frias DV, Cajulis RS et al: Postconization endocervical smear: evaluation of its utility in the detection of residual dysplasia. Acta Cytol 42(5): 1139-1143, 1998.